Skip to main content
MedicHelpLine
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsNASALGeneric

FLUNISOLIDE

FLUNISOLIDE

Standard Dose
0.029MG/SPRAY
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview FLUNISOLIDE is listed in Drugs@FDA under application 077436 (ANDA).

Marketing status: Discontinued Active ingredient FLUNISOLIDE Form and strength SPRAY, METERED;NASAL - 0.029MG/SPRAY Sponsor APOTEX Submission history Latest submission status date: 2007-08-09 00:00:00.

Structured Monograph

Clinical summary

Approval overview FLUNISOLIDE is listed in Drugs@FDA under application 077436 (ANDA). Marketing status: Discontinued Active ingredient FLUNISOLIDE Form and strength SPRAY, METERED;NASAL - 0.029MG/SPRAY Sponsor APOTEX Submission history Latest submission status date: 2007-08-09 00:00:00. Submission type: ORIG.

Monitoring

  • Review priority: STANDARD
  • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.